HK1207290A1 - Oral formulation - Google Patents
Oral formulation Download PDFInfo
- Publication number
- HK1207290A1 HK1207290A1 HK15107872.1A HK15107872A HK1207290A1 HK 1207290 A1 HK1207290 A1 HK 1207290A1 HK 15107872 A HK15107872 A HK 15107872A HK 1207290 A1 HK1207290 A1 HK 1207290A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- oral formulation
- substrate
- water
- gelling agent
- sugar alcohol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261640474P | 2012-04-30 | 2012-04-30 | |
| US61/640,474 | 2012-04-30 | ||
| US201361783163P | 2013-03-14 | 2013-03-14 | |
| US61/783,163 | 2013-03-14 | ||
| PCT/JP2013/062985 WO2013165021A1 (en) | 2012-04-30 | 2013-04-30 | Oral formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1207290A1 true HK1207290A1 (en) | 2016-01-29 |
Family
ID=48483123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15107872.1A HK1207290A1 (en) | 2012-04-30 | 2013-04-30 | Oral formulation |
Country Status (21)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109498556A (zh) * | 2017-09-15 | 2019-03-22 | 万特制药(海南)有限公司 | 阿立哌唑口服溶液及其制备方法 |
| WO2022176017A1 (ja) * | 2021-02-16 | 2022-08-25 | 大塚製薬株式会社 | 非晶質体及び当該非晶質体を含む組成物 |
| US11654108B1 (en) | 2022-05-02 | 2023-05-23 | Medicated Chews, Llc | Sennoside medicated chews |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6517886B1 (en) * | 1997-06-24 | 2003-02-11 | Biovail Corporation International | Positive hydration method of preparing confectionery and the resulting product |
| AUPQ970300A0 (en) * | 2000-08-29 | 2000-09-21 | Massa Nominees Pty Ltd | Advanced wireless network |
| FR2822644B1 (fr) * | 2001-03-30 | 2005-03-11 | Roquette Freres | Confiserie sans sucre |
| JP2004099558A (ja) * | 2002-09-11 | 2004-04-02 | Medorekkusu:Kk | 医薬用ゼリー組成物 |
| JP4547994B2 (ja) * | 2004-06-02 | 2010-09-22 | 救急薬品工業株式会社 | 塊状物質含有積層フィルム状の可食性口腔内投与剤の製造方法および塊状物質含有積層フィルム状の可食性口腔内投与剤 |
| JP4315393B2 (ja) | 2005-04-14 | 2009-08-19 | 大塚製薬株式会社 | 複素環化合物 |
| WO2008050847A1 (en) * | 2006-10-25 | 2008-05-02 | Dainippon Sumitomo Pharma Co., Ltd. | Granular preparation prevented from caking |
| AU2008237246B2 (en) * | 2007-04-05 | 2014-06-05 | University Of Kansas | Rapidly dissolving pharmaceutical compositions comprising pullulan |
| GB0818472D0 (en) * | 2008-10-08 | 2008-11-12 | Probio Nutraceuticals As | Composition |
| WO2010116385A2 (en) * | 2009-04-08 | 2010-10-14 | Rubicon Research Private Limited | Pharmaceutical compositions for alleviating unpleasant taste |
| KR101074271B1 (ko) * | 2009-06-25 | 2011-10-17 | (주)차바이오앤디오스텍 | 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름 |
| US20110139164A1 (en) * | 2009-12-15 | 2011-06-16 | R. J. Reynolds Tobacco Company | Tobacco Product And Method For Manufacture |
| GB201006200D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| JP5611672B2 (ja) * | 2010-05-28 | 2014-10-22 | ゼリア新薬工業株式会社 | 経口ゼリー剤 |
| AR082494A1 (es) * | 2010-08-24 | 2012-12-12 | Otsuka Pharma Co Ltd | Composicion en torta y en suspension con contenido de derivado de carbostirilo y derivado de aceite de silicona y/o aceite de silicona |
| GB201016900D0 (en) * | 2010-10-06 | 2010-11-17 | Probio Asa | Emulsion |
| WO2014104989A1 (en) * | 2011-12-27 | 2014-07-03 | Mahmut Bilgic | Pharmaceutical compositions comprising aripiprazole |
-
2013
- 2013-04-29 AR ARP130101449 patent/AR091349A1/es unknown
- 2013-04-29 TW TW102115265A patent/TWI594765B/zh not_active IP Right Cessation
- 2013-04-30 MX MX2014013155A patent/MX2014013155A/es unknown
- 2013-04-30 WO PCT/JP2013/062985 patent/WO2013165021A1/en not_active Ceased
- 2013-04-30 EA EA201491995A patent/EA026187B1/ru not_active IP Right Cessation
- 2013-04-30 US US14/397,683 patent/US20150126521A1/en not_active Abandoned
- 2013-04-30 CN CN201380022960.1A patent/CN104271120A/zh active Pending
- 2013-04-30 HK HK15107872.1A patent/HK1207290A1/xx unknown
- 2013-04-30 EP EP13724634.4A patent/EP2844232A1/en not_active Withdrawn
- 2013-04-30 CA CA 2872004 patent/CA2872004A1/en not_active Abandoned
- 2013-04-30 IN IN9091DEN2014 patent/IN2014DN09091A/en unknown
- 2013-04-30 SG SG11201406261QA patent/SG11201406261QA/en unknown
- 2013-04-30 AU AU2013255256A patent/AU2013255256B2/en not_active Ceased
- 2013-04-30 KR KR1020147033472A patent/KR20150003898A/ko not_active Withdrawn
- 2013-04-30 JP JP2014553002A patent/JP6360795B2/ja active Active
- 2013-04-30 BR BR112014026879A patent/BR112014026879A2/pt not_active IP Right Cessation
- 2013-04-30 SG SG10201608954UA patent/SG10201608954UA/en unknown
- 2013-04-30 NZ NZ630029A patent/NZ630029A/en not_active IP Right Cessation
-
2014
- 2014-10-17 PH PH12014502323A patent/PH12014502323A1/en unknown
- 2014-10-19 IL IL235111A patent/IL235111A0/en unknown
- 2014-11-06 ZA ZA2014/08114A patent/ZA201408114B/en unknown
- 2014-11-26 CO CO14260294A patent/CO7151505A2/es unknown
-
2017
- 2017-04-05 US US15/479,409 patent/US20170202833A1/en not_active Abandoned
- 2017-10-27 US US15/795,500 patent/US20180055840A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL235111A0 (en) | 2014-12-31 |
| IN2014DN09091A (cg-RX-API-DMAC7.html) | 2015-05-22 |
| CO7151505A2 (es) | 2014-12-29 |
| ZA201408114B (en) | 2016-08-31 |
| CA2872004A1 (en) | 2013-11-07 |
| PH12014502323A1 (en) | 2015-01-12 |
| JP2015515959A (ja) | 2015-06-04 |
| EP2844232A1 (en) | 2015-03-11 |
| AR091349A1 (es) | 2015-01-28 |
| WO2013165021A1 (en) | 2013-11-07 |
| MX2014013155A (es) | 2015-05-08 |
| NZ630029A (en) | 2016-05-27 |
| SG10201608954UA (en) | 2016-12-29 |
| EA026187B1 (ru) | 2017-03-31 |
| TW201347773A (zh) | 2013-12-01 |
| SG11201406261QA (en) | 2014-11-27 |
| US20150126521A1 (en) | 2015-05-07 |
| JP6360795B2 (ja) | 2018-07-18 |
| KR20150003898A (ko) | 2015-01-09 |
| AU2013255256A2 (en) | 2014-11-13 |
| TWI594765B (zh) | 2017-08-11 |
| AU2013255256A1 (en) | 2014-10-30 |
| US20170202833A1 (en) | 2017-07-20 |
| CN104271120A (zh) | 2015-01-07 |
| EA201491995A1 (ru) | 2015-02-27 |
| US20180055840A1 (en) | 2018-03-01 |
| AU2013255256B2 (en) | 2017-09-07 |
| BR112014026879A2 (pt) | 2017-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014039903A3 (en) | Stable aqueous formulations of adalimumab | |
| WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
| WO2012076293A9 (de) | Zubereitungen enthaltend polysiloxane mit stickstoffhaltigen gruppen | |
| WO2012100224A3 (en) | Preparation of metal-triazolate frameworks | |
| WO2011130615A3 (en) | Preparation of lacosamide | |
| WO2010021607A3 (en) | Pharmaceutical formulation | |
| WO2013173789A3 (en) | Antisense oligonucleotide compositions | |
| WO2012102799A3 (en) | Method, composition and package for bowel cleansing | |
| WO2010030598A3 (en) | Pharmaceutical formulations comprising pemetrexed | |
| HK1206028A1 (en) | Phenicol antibacterials | |
| EP3878445A3 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| WO2014144295A8 (en) | Ceftolozane antibiotic compositions | |
| WO2014165226A3 (en) | Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar | |
| WO2013017967A3 (en) | Antimicrobial cleansing compositions | |
| EP3067059A4 (en) | Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient | |
| WO2013134534A3 (en) | Solid state forms of cabazitaxel and processes for preparation thereof | |
| WO2012087327A3 (en) | Polymer systems | |
| WO2010046061A3 (de) | Kosmetische und/oder pharmazeutische zubereitungen | |
| PH12012501548A1 (en) | Compositions comprising sugar-cysteine products | |
| WO2013170086A3 (en) | Formulations for the delivery of active ingredients | |
| HK1207290A1 (en) | Oral formulation | |
| WO2014133811A3 (en) | Compounds from invasive salvinias and methods of using the same | |
| HK1199841A1 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| MX2014015199A (es) | Formulacion de pexiganan estable. | |
| WO2013018091A8 (en) | Particles for the treatment of neurodegenerative diseases |